
April 6, 2011 – One-year results from the pivotal PLATINUM Workhorse trial were presented at the American College of Cardiology (ACC) Scientific Session in New Orleans. The trial compared the safety and effectiveness of Boston Scientific’s Promus Element everolimus-eluting platinum chromium (PtCr) coronary stent to the Promus everolimus-eluting coronary stent.
April 6, 2011 – A new fully integrated cardiovascular picture archiving and communications system (PACS) and certified electronic medical record (EMR) with a Web-based cardiovascular electronic whiteboard has been launched. The components, which are part of Medstreaming’s cardiovascular information system (CVIS) platform, offer a U.S.
April 6, 2011 – Ultrasound is often used as a first-line diagnostic exam to quickly and safely diagnose a range of patient conditions. At this year’s American College of Cardiology (ACC) annual meeting in New Orleans Toshiba America Medical Systems highlighted new enhancements to its cardiac and shared service ultrasound systems that are designed to enhance cardiac ultrasound imaging.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
April 6, 2011 – Development of a novel embolic protection device designed for use during transcatheter aortic valve implantation (TAVI) procedures received $10.5 million in funding. SMT Research and Development (SMT) of Israel announced the significant investment by OrbiMed Advisors.
April 6, 2011 – At the American College of Cardiology’s 60th Annual Scientific Session, Siemens Healthcare demonstrated solution for sustainable cardiovascular care.
April 6, 2011 – Results from a pooled patient-level analysis favored a next-generation paclitaxel-eluting stent. Data from the PERSEUS and TAXUS ATLAS trials compared Boston Scientific’s Ion Platinum-Chromium (PtCr) to the Taxus Liberte Paclitaxel-Eluting Stent System.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

April 6, 2011 – The second phase of a trial evaluating the world’s first drug-eluting bioresorbable vascular scaffold (BVS) showed positive one-year results. Data from the ABSORB Trial, which looked at Abbott’s BVS, were presented at the American College of Cardiology's (ACC) Scientific Session in New Orleans.

April 6, 2011 – A pooled analysis of the SPIRIT II, III, IV and COMPARE trials further reinforces the positive clinical performance of an everolimus eluting coronary stent system.
April 5, 2011 – A microcatheter system has received the CE mark. The Plato Microcath system, by Scientia Vascular, is now available in Europe for neuro, cardio and peripheral endovascular applications.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 5, 2011 – Uterine fibroid embolization—an interventional radiology treatment for noncancerous growths that develop in the muscular wall of the uterus—improves a number of women's lower urinary tract problems that are specifically caused by those fibroids. The finding was announced by researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago.

April 5, 2011 – Death rates are similar at one year for a catheter-based aortic valve replacement procedure and conventional surgery in older high-risk patients.
April 4, 2011 – Reducing cardiovascular risk factors such as high blood pressure, smoking, diabetes and being overweight could potentially reduce more than half of all cases of atrial fibrillation, according to research reported in Circulation: Journal of the American Heart Association.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
April 4, 2011 – The U.S. Food and Drug Administration (FDA) has approved a 210-patient investigation devices exemption (IDE) clinical trial to test the efficacy of a bone marrow stem cell technology in patients with non-reconstructable critical limb ischemia (CLI).
April 4, 2011 – An updated software release for a cardiovascular information system (CVIS) has now consolidated everything into a single database, including hemodynamics. The 12.2 release of McKesson’s Horizon Cardiology presents the entire patient history, from fetal to adulthood.
April 4, 2011 – Doctors are encouraged to consider therapies in addition to blood thinners to treat certain patients with potentially dangerous blood clots that form in the deep veins and travel to the lungs, according to a new scientific statement from the American Heart Association. The statement is published online in Circulation: Journal of the American Heart Association.